163 related articles for article (PubMed ID: 19136605)
1. Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury.
Hiraumi Y; Iwai-Kanai E; Baba S; Yui Y; Kamitsuji Y; Mizushima Y; Matsubara H; Watanabe M; Watanabe K; Toyokuni S; Matsubara H; Nakahata T; Adachi S
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H823-32. PubMed ID: 19136605
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats.
Hou XW; Son J; Wang Y; Ru YX; Lian Q; Majiti W; Amazouzi A; Zhou YL; Wang PX; Han ZC
Cardiovasc Drugs Ther; 2006 Apr; 20(2):85-91. PubMed ID: 16761189
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy.
Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Ogino A; Maruyama R; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
Lab Invest; 2007 May; 87(5):440-55. PubMed ID: 17334414
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes.
Liu TJ; Yeh YC; Ting CT; Lee WL; Wang LC; Lee HW; Wang KY; Lai HC; Lai HC
Cardiovasc Res; 2008 Nov; 80(2):227-35. PubMed ID: 18632596
[TBL] [Abstract][Full Text] [Related]
7. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Sergi C; Keschrumrus V; Churko JM; Granzier H; Schulz R
Cardiovasc Res; 2021 Jan; 117(1):188-200. PubMed ID: 31995179
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy.
Zhang M; Wei J; Shan H; Wang H; Zhu Y; Xue J; Lin L; Yan R
PLoS One; 2013; 8(6):e66779. PubMed ID: 23818963
[TBL] [Abstract][Full Text] [Related]
9. FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress.
Chaanine AH; Kohlbrenner E; Gamb SI; Guenzel AJ; Klaus K; Fayyaz AU; Nair KS; Hajjar RJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1540-H1559. PubMed ID: 27694219
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
[TBL] [Abstract][Full Text] [Related]
12. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.
Dhingra R; Margulets V; Chowdhury SR; Thliveris J; Jassal D; Fernyhough P; Dorn GW; Kirshenbaum LA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5537-44. PubMed ID: 25489073
[TBL] [Abstract][Full Text] [Related]
13. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2.
Diotte NM; Xiong Y; Gao J; Chua BH; Ho YS
Biochim Biophys Acta; 2009 Feb; 1793(2):427-38. PubMed ID: 19038292
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
Barış VÖ; Dinçsoy AB; Gedikli E; Zırh S; Müftüoğlu S; Erdem A
Cardiovasc Toxicol; 2021 Sep; 21(9):747-758. PubMed ID: 34089496
[TBL] [Abstract][Full Text] [Related]
18. Quercetin protects cardiomyocytes against doxorubicin-induced toxicity by suppressing oxidative stress and improving mitochondrial function via 14-3-3γ.
Chen X; Peng X; Luo Y; You J; Yin D; Xu Q; He H; He M
Toxicol Mech Methods; 2019 Jun; 29(5):344-354. PubMed ID: 30636491
[TBL] [Abstract][Full Text] [Related]
19. Shenfu injection prevents sepsis-induced myocardial injury by inhibiting mitochondrial apoptosis.
Xu P; Zhang WQ; Xie J; Wen YS; Zhang GX; Lu SQ
J Ethnopharmacol; 2020 Oct; 261():113068. PubMed ID: 32592888
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Dysfunction in the Sigma 1 Receptor Knockout Mouse Associated With Impaired Mitochondrial Dynamics and Bioenergetics.
Abdullah CS; Alam S; Aishwarya R; Miriyala S; Panchatcharam M; Bhuiyan MAN; Peretik JM; Orr AW; James J; Osinska H; Robbins J; Lorenz JN; Bhuiyan MS
J Am Heart Assoc; 2018 Oct; 7(20):e009775. PubMed ID: 30371279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
